These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7312078)

  • 21. [External radiotherapy in early stage squamous cell carcinoma of the supraglottic larynx. Report of 28 cases].
    Caliceti U; Frezza G; Galuppi A; Guidetti A; Pasquini E; Sorrenti G; Cavicchi O; Rinaldi Ceroni A
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):35-9. PubMed ID: 8984838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
    Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiotherapy of T1N0 neoplasms of the glottis. Analysis of the parameters that influence local control].
    Bolner A; Valentini A; Amichetti M; Busana L; Fellin G; Menegotti L; Nassivera E; Pani G; Romano M
    Radiol Med; 1995 Dec; 90(6):804-7. PubMed ID: 8685467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiation treatment of early stage supraglottic cancer].
    Spriano G; Ferrario F; Roselli R; Piantanida R; Antognoni P
    Ann Otolaryngol Chir Cervicofac; 1999 May; 116(2):66-70. PubMed ID: 10378034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TN/TN glottic carcinoma: a comparison of two fractionation schedules.
    Short S; Krawitz H; Macann A; West T; Morton RP; McIvor NP; Chaplin J; Simcock P; Gathercole J; Dorman B; Hindley A
    Australas Radiol; 2006 Apr; 50(2):152-7. PubMed ID: 16635034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
    Deore SM; Supe SJ; Sharma V; Dinshaw KA
    Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation.
    Wygoda A; Maciejewski B; Skladowski K; Hutnik M; Pilecki B; Golen M; Rutkowski T
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):384-90. PubMed ID: 18374510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer.
    Suwiński R; Bańkowska-Woźniak M; Majewski W; Idasiak A; Maciejewski A; Ziółkowska E; Windorbska W; Składowski K; Miszczyk L; Maciejewski B
    Radiother Oncol; 2008 May; 87(2):155-63. PubMed ID: 18342964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose response in radiotherapy for glottic carcinoma.
    Karim AB; Snow GB; Hasman A; Chang SC; Keilholtz A; Hoekstra F
    Cancer; 1978 May; 41(5):1728-32. PubMed ID: 417795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-stage glottic cancer: importance of dose fractionation in radiation therapy.
    Kim RY; Marks ME; Salter MM
    Radiology; 1992 Jan; 182(1):273-5. PubMed ID: 1727295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic postoperative radiotherapy in the treatment of supraglottic tumors].
    Esposito E; Motta S; Cassiano B; Motta G
    Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):432-41. PubMed ID: 11398681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
    Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
    Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early stages of laryngeal cancer (I-II stage) and therapeutic options: case report and review of literature].
    Margarino G; Schenone G; Scala M; Mereu P; Comandini D; Corvo R; Scolaro T; Badellino F
    Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):40-6. PubMed ID: 8984839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative radiotherapy under hyperbaric oxygenation of locally disseminated cancer of the larynx using a reduced total focal dose].
    Dar'ialova SL; Sukirko VA; Klochikhin AL; Bitiutskiĭ PG; Frank GA
    Med Radiol (Mosk); 1988 Apr; 33(4):31-5. PubMed ID: 3357389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
    Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
    Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.